• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    Takeda Announces New Assignments of Directors

    June 29, 2021

    OSAKA, Japan, June 29, 2021, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK)

    (“Takeda”) today announced new assignment of Directors. The details are as follows;

     

    Directors Who are Not Audit and Supervisory Committee Members

     

    1. New assignment of Non-Audit and Supervisory Committee Directors effective June 29, 2021;

    Name

    Category

    Expected Role

    Christophe Weber

    Internal

    Existing

    Representative Director,

    President & Chief Executive Officer

    Masato Iwasaki

    Internal

    Existing

    Representative Director, Japan General Affairs

    Andrew Plump

    Internal

    Existing

    Director, President, Research & Development

    Constantine Saroukos

    Internal

    Existing

    Director, Chief Financial Officer

    Masahiro Sakane

    External

    Existing

    External Director, Chair of the Board Meeting

    Olivier Bohuon

    External

    Existing

    External Director

    Jean-Luc Butel

    External

    Existing

    External Director

    Ian Clark

    External

    Existing

    External Director

    Yoshiaki Fujimori

    External

    Existing

    External Director

    Steven Gillis

    External

    Existing

    External Director

    Shiro Kuniya

    External

    Existing

    External Director

    Toshiyuki Shiga

    External

    Existing

    External Director

     

    1. New assignment of Audit and Supervisory Committee Directors effective June 29, 2021;

     

    Name

    Category

    Expected Role

    Koji Hatsukawa

    External

    -

    External Director, Chairperson of Audit and Supervisory Committee

    Emiko Higashi

    External

    -

    External Director, Audit and Supervisory Committee Member

    Masami Iijima

    External

    New

    External Director, Audit and Supervisory Committee Member

    Michel Orsinger

    External

    -

    External Director, Audit and Supervisory Committee Member

     

    Koji Hatsukawa, Emiko Higashi, and Michel Orsinger are within their 2-year tenure of Audit and Supervisory Committee Director, and were not subjects for reelection this year.

     

    1. New assignment of Compensation committee and Nomination committee effective June 29, 2021;

     

    Compensation committee : Emiko Higashi (Chair), Olivier Bohuon, Ian Clark, Yoshiaki Fujimori
    Nomination committee : Masahiro Sakane (Chair), Jean-Luc Butel, Steven Gillis,
    Toshiyuki Shiga, Michel Orsinger, Christophe Weber (Observer)

     

    About Takeda Pharmaceutical Company Limited
    Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven
    biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. For more information, visit http://www.asiamerlion.cn.

     

    Media Contacts:
    Japanese Media
    Ryoko Matsumoto
    ryoko.matsumoto@takeda.com
    +81 (0) 3-3278-3414

     

    Media Outside Japan
    Christina Beckerman
    christina.beckerman@takeda.com
    +1 (908) 581-4133

     

    国产AV网站_中午文字幕av一区二区三区_性进入裸体视频_久久久久久精品免费免费直播